Skip to content

DR. PETER SANSEN

Active
Private limited companyfounded 201214 yrs activeFeutenaarstraat 5, 8970 Poperinge, BelgiumKBO/BCE: BE 0844.499.915

DR. PETER SANSEN has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €317k and a net result of €43k. Equity remains stable across the filed fiscal years (±1.7% per year). Its solvency ranks better than 27% of 16408 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
91 / 100
Excellent▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability68▲+10
Solvency73▲+12
Growth78▲+20
Stability100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.02 against 1.76 in 2024), but 67.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
32.6%
Return on assets
4.4%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 14 years 0 20 y
lowers risk · Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €317k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-07-2026, 6 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
6 d early
2024
61 d late
2023
30 d late
2022
72 d late
2021
25 d late
2020
3 d early
2019
7 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€317k▲ 15.6%
2024 · €274k
2018: €297k 2019: €345k 2020: €386k 2021: €281k 2022: €249k 2023: €261k 2024: €274k
2018 → 2025
Total assets
€970k=
2024 · €970k
2018: €478k 2019: €519k 2020: €529k 2021: €499k 2022: €910k 2023: €1.02M 2024: €970k
2018 → 2025
Net result
€43k▲ 34.7%
2024 · €32k
2018: €19k 2019: €49k 2020: €41k 2021: €26k 2022: €11k 2023: €43k 2024: €32k
2018 → 2025
Working capital
€116k▲ 50.3%
2024 · €77k
2018: €259k 2019: €324k 2020: €381k 2021: €283k 2022: €523k 2023: €258k 2024: €77k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€281k-€249k▼ 11.2%€261k▲ 4.8%€274k▲ 4.9%€317k▲ 15.6%
Operating result€48k-€17k▼ 65.3%€66k▲ 301%€65k▼ 1.4%€81k▲ 23.8%
Net result€26k-€11k▼ 59.0%€43k▲ 305%€32k▼ 25.5%€43k▲ 34.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25k€50k€75kOperating result 2021: €48k€48kNet result 2021: €26k€26kOperating result 2022: €17k€17kNet result 2022: €11k€11kOperating result 2023: €66k€66kNet result 2023: €43k€43kOperating result 2024: €65k€65kNet result 2024: €32k€32kOperating result 2025: €81k€81kNet result 2025: €43k€43k20212022202320242025
The operating result recovers in 2025; 2025 is 24% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €970k
Fixed assets €741k▼ 6.4%
Current assets €229k▲ 28.5%
Equity and liabilities €970k
Equity €317k▲ 15.6%
Debt €654k▼ 6.2%
The debt ratio falls from 71.8% to 67.4%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€143k
2024 · €117k
Cash flow
€105k
2024 · €83k
Solvency
32.6%
2024 · 28.2%
Current ratio
2.02
2024 · 1.76
Quick ratio
2.02
2024 · 1.76
Debt / equity
2.06
2024 · 2.54
ROE
13.5%
2024 · 11.6%
ROA
4.4%
2024 · 3.3%
Interest coverage
6.87
2024 · 5.37
Debt
€654k
2024 · €696k
Debt ≤ 1 year
€114k
2024 · €101k
Debt > 1 year
€540k
2024 · €594k
Income taxes
€17k
2024 · €12k
Staff costs
€32k
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€970k€970k=
Fixed assets21/28€792k€741k
Intangible fixed assets21€803€212
Tangible fixed assets22/27€791k€741k
Land and buildings22€652k€631k
Plant, machinery and equipment23€99k€98k
Furniture and vehicles24€18k€11k
Other tangible fixed assets26€21k-
Current assets29/58€178k€229k
Amounts receivable within one year40/41€12k€29k
Trade receivables40€7k€14k
Other amounts receivable41€5k€14k
Cash at bank and in hand54/58€47k€89k
Deferred charges and accrued income490/1€120k€112k
Equity and liabilities
Total equity and liabilities10/49€970k€970k=
Equity10/15€274k€317k
Contributions10/11€50k€50k=
Reserves13€224k€267k
Distributable reserves133€224k€267k
Amounts payable17/49€696k€654k
Amounts payable after more than one year17€594k€540k
Financial debts170/4€594k€540k
Amounts payable within one year42/48€101k€114k
Current portion of amounts payable after more than one year42€53k€54k
Financial debts43€9k€15k
Credit institutions430/8€9k€15k
Trade debts44€15k€22k
Suppliers440/4€15k€22k
Taxes, remuneration and social security45€12k€12k
Taxes450/3€2k€2k
Remuneration and social security454/9€10k€10k
Other amounts payable47/48€14k€10k
Accrued charges and deferred income492/3€1k-
Income statement Code20242025
Remuneration, social security and pensions62€41k€32k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€52k€62k
Other operating charges640/8€18k€20k
Non-recurring operating charges66A-€21k
Gross operating margin9900€176k€217k
Operating profit (loss)9901€65k€81k
Financial income75/76B€110€0
Recurring financial income75€110€0
Financial charges65/66B€22k€21k
Recurring financial charges65€22k€21k
Profit (loss) for the period before taxes9903€44k€60k
Income taxes67/77€12k€17k
Profit (loss) for the period9904€32k€43k
Profit (loss) for the period to be appropriated9905€32k€43k
Appropriation of the result
Profit (loss) to be appropriated9906€32k€43k
Transfer from equity791/2€19k-
Transfer to equity691/2€32k€43k
To other reserves6921€32k€43k
Profit to be distributed694/7€19k-
Return on contributions (dividend)694€19k-

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
30-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
11-10
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 72 days late
2022
31-12
Financial Weakest financial yearnet €11k ▼59%
Net result drops to €11k, the lowest in the series; recovery starts the following year.
25-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 25 days late
2021
28-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
07-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 7 days late
2019
31-12
Financial Highest result since 2018net €49k ▲160%
Net result €49k, the highest in the series.
27-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
23-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
22-06
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Poperinge · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Feutenaarstraat 58970 Poperinge
Ground area
1.3 ha
Building footprint
282 m²
Volume, LiDAR
1,587 m³
Parcel 33023B0248/00M000, Flanders · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. PETER SANSEN
Feutenaarstraat 5, 8970 PoperingeGeneral medical practice
since 20122.234.060.448
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
33023B0248/00M000 Flanders 1.3 ha 1 · 282 m² 9.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,101 companies in sector 86210 we hold annual accounts for 6,323. 5,189 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-03-2012
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
72101Research and development on biotechnology
72109Other research and development on natural sciences
82100Office administrative and support services
82190Office administrative, office support and other business support activities
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.